Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuzeon Induction in HIV-1 Patients With Virological Failure
NCT00615134Phase 2Completed
- Sponsor
- Roche
- Start
- Jan 2008
- Primary completion
- Jun 2011
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of enfuvirtide in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Roche. Started Jan 2008; status: completed.
02
Drugs
enfuvirtide
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00615134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00615134.